Theratechnologies Inc. Files 6-K for Annual Shareholder Meeting

Theratechnologies Inc. 6-K Filing Summary
FieldDetail
CompanyTheratechnologies Inc.
Form Type6-K
Filed DateMay 2, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: shareholder-meeting, proxy-filing, corporate-governance

Related Tickers: TH.TO

TL;DR

Theratechnologies (TH) filed its 6-K for the May 2025 shareholder meeting, including proxy docs dated April 30.

AI Summary

Theratechnologies Inc. filed a Form 6-K on May 2, 2025, to report on its upcoming Annual Meeting of Shareholders. The meeting is scheduled, and related documents, including the Notice of Annual Meeting of Shareholders dated April 30, 2025, and the Management Proxy Circular dated April 30, 2025, were filed.

Why It Matters

This filing provides shareholders with essential information and documents for the upcoming annual meeting, allowing them to participate in corporate governance.

Risk Assessment

Risk Level: low — This filing is routine administrative information regarding a shareholder meeting and does not contain new financial or operational risks.

Key Players & Entities

  • Theratechnologies Inc. (company) — Registrant
  • April 30, 2025 (date) — Date of Notice of Annual Meeting and Proxy Circular
  • May 2, 2025 (date) — Filing Date of Form 6-K
  • Jocelyn Lafond (person) — General Counsel and Corporate Secretary

FAQ

What is the purpose of this Form 6-K filing?

The purpose of this Form 6-K is to report information that Theratechnologies Inc. is required to disclose to its shareholders, specifically related to its Annual Meeting of Shareholders.

When was the Notice of Annual Meeting of Shareholders dated?

The Notice of Annual Meeting of Shareholders was dated April 30, 2025.

What other documents were filed along with the Notice of Annual Meeting?

Along with the Notice of Annual Meeting, the Management Proxy Circular dated April 30, 2025, and a Form of Proxy were filed.

What is the principal executive office address of Theratechnologies Inc.?

The principal executive office address of Theratechnologies Inc. is 2015 Peel Street, Suite 1100, Montreal, Quebec H3A 1T8, Canada.

Who signed this Form 6-K on behalf of Theratechnologies Inc.?

Jocelyn Lafond, General Counsel and Corporate Secretary, signed this Form 6-K on behalf of Theratechnologies Inc.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on May 2, 2025 by Jocelyn Lafond regarding Theratechnologies Inc..

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.